BEAM
Price
$19.87
Change
+$0.74 (+3.87%)
Updated
Apr 23 closing price
Capitalization
1.92B
19 days until earnings call
CRSP
Price
$38.54
Change
-$0.69 (-1.76%)
Updated
Apr 23 closing price
Capitalization
3.39B
18 days until earnings call
Ad is loading...

BEAM vs CRSP

Header iconBEAM vs CRSP Comparison
Open Charts BEAM vs CRSPBanner chart's image
Beam Therapeutics
Price$19.87
Change+$0.74 (+3.87%)
Volume$2.13M
Capitalization1.92B
CRISPR Therapeutics AG
Price$38.54
Change-$0.69 (-1.76%)
Volume$1.9M
Capitalization3.39B
BEAM vs CRSP Comparison Chart
Loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
BEAM vs. CRSP commentary
Apr 24, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BEAM is a Buy and CRSP is a Buy.

Ad is loading...
COMPARISON
Comparison
Apr 24, 2025
Stock price -- (BEAM: $19.87 vs. CRSP: $38.54)
Brand notoriety: BEAM and CRSP are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: BEAM: 84% vs. CRSP: 86%
Market capitalization -- BEAM: $1.92B vs. CRSP: $3.39B
BEAM [@Biotechnology] is valued at $1.92B. CRSP’s [@Biotechnology] market capitalization is $3.39B. The market cap for tickers in the [@Biotechnology] industry ranges from $266.85B to $0. The average market capitalization across the [@Biotechnology] industry is $2.09B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

BEAM’s FA Score shows that 0 FA rating(s) are green whileCRSP’s FA Score has 0 green FA rating(s).

  • BEAM’s FA Score: 0 green, 5 red.
  • CRSP’s FA Score: 0 green, 5 red.
According to our system of comparison, BEAM is a better buy in the long-term than CRSP.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

BEAM’s TA Score shows that 4 TA indicator(s) are bullish while CRSP’s TA Score has 5 bullish TA indicator(s).

  • BEAM’s TA Score: 4 bullish, 5 bearish.
  • CRSP’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, CRSP is a better buy in the short-term than BEAM.

Price Growth

BEAM (@Biotechnology) experienced а +19.55% price change this week, while CRSP (@Biotechnology) price change was +2.01% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +8.04%. For the same industry, the average monthly price growth was -8.89%, and the average quarterly price growth was -12.57%.

Reported Earning Dates

BEAM is expected to report earnings on Aug 12, 2025.

CRSP is expected to report earnings on Aug 11, 2025.

Industries' Descriptions

@Biotechnology (+8.04% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
CRSP($3.39B) has a higher market cap than BEAM($1.92B). CRSP YTD gains are higher at: -2.083 vs. BEAM (-19.879). BEAM has higher annual earnings (EBITDA): -383.98M vs. CRSP (-447.31M). CRSP has more cash in the bank: 1.9B vs. BEAM (851M). BEAM has less debt than CRSP: BEAM (161M) vs CRSP (224M). BEAM has higher revenues than CRSP: BEAM (63.5M) vs CRSP (35M).
BEAMCRSPBEAM / CRSP
Capitalization1.92B3.39B57%
EBITDA-383.98M-447.31M86%
Gain YTD-19.879-2.083954%
P/E RatioN/AN/A-
Revenue63.5M35M181%
Total Cash851M1.9B45%
Total Debt161M224M72%
FUNDAMENTALS RATINGS
CRSP: Fundamental Ratings
CRSP
OUTLOOK RATING
1..100
54
VALUATION
overvalued / fair valued / undervalued
1..100
67
Overvalued
PROFIT vs RISK RATING
1..100
100
SMR RATING
1..100
92
PRICE GROWTH RATING
1..100
76
P/E GROWTH RATING
1..100
71
SEASONALITY SCORE
1..100
50

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
BEAMCRSP
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bullish Trend 1 day ago
78%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
90%
Bearish Trend 1 day ago
85%
Momentum
ODDS (%)
Bullish Trend 1 day ago
79%
Bullish Trend 1 day ago
77%
MACD
ODDS (%)
Bullish Trend 1 day ago
83%
Bullish Trend 1 day ago
68%
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
82%
Bearish Trend 1 day ago
82%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
84%
Bearish Trend 1 day ago
86%
Advances
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 3 days ago
81%
Declines
ODDS (%)
Bearish Trend 21 days ago
85%
Bearish Trend 8 days ago
84%
BollingerBands
ODDS (%)
Bearish Trend 1 day ago
90%
Bullish Trend 1 day ago
74%
Aroon
ODDS (%)
Bearish Trend 1 day ago
87%
Bearish Trend 1 day ago
84%
View a ticker or compare two or three
Ad is loading...
BEAM
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
CRSP
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
JERTX11.41N/A
N/A
Janus Henderson Global Real Estate T
FSSEX10.91N/A
N/A
Fidelity SAI Sustainable Intl Eq
DFIEX16.71N/A
N/A
DFA International Core Equity 2 I
BRBCX13.94N/A
N/A
BlackRock Tactical Opportunities Inv C
NBHEX13.68N/A
N/A
Neuberger Berman Equity Income E

BEAM and

Correlation & Price change

A.I.dvisor indicates that over the last year, BEAM has been closely correlated with CRSP. These tickers have moved in lockstep 70% of the time. This A.I.-generated data suggests there is a high statistical probability that if BEAM jumps, then CRSP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To BEAM
1D Price
Change %
BEAM100%
+3.87%
CRSP - BEAM
70%
Closely correlated
-1.76%
NTLA - BEAM
64%
Loosely correlated
-2.65%
RXRX - BEAM
62%
Loosely correlated
-0.89%
DNLI - BEAM
59%
Loosely correlated
+1.85%
PRME - BEAM
59%
Loosely correlated
+4.14%
More

CRSP and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRSP has been closely correlated with RXRX. These tickers have moved in lockstep 72% of the time. This A.I.-generated data suggests there is a high statistical probability that if CRSP jumps, then RXRX could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRSP
1D Price
Change %
CRSP100%
-1.76%
RXRX - CRSP
72%
Closely correlated
-0.89%
BEAM - CRSP
71%
Closely correlated
+3.87%
NTLA - CRSP
66%
Loosely correlated
-2.65%
PRME - CRSP
63%
Loosely correlated
+4.14%
ABCL - CRSP
62%
Loosely correlated
+0.79%
More